Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05765201 · ClinicalTrials.gov registry record
Phacoemulsification at High IOP and Physiologic IOP: Impact on Anterior and Posterior Segment Physiology
A clinical trial, sponsored by Matthew Rauen.
- Completed
- Registry status
- 27
- Enrollment target
NCT05765201 is a clinical trial that has completed, run by Matthew Rauen. The registered enrollment target is 27 participants.
The verdict
NCT05765201 has completed, sponsored by Matthew Rauen.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the anterior and posterior structure and functional changes and vascular alterations when performing phacoemulsification at high IOP vs low, more physiological IOP using Centurion® Vision System with Active Sentry® handpiece. These devices are approved by the US Food and Drug Administration (FDA).
Interventions
- OTHER High IOP
- OTHER Low IOP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2022-09-22 |
| Est. Completion | 2023-05-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05765201
The ClinicalTrials.gov registry entry for NCT05765201 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Matthew Rauen, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High IOP is the first listed.
NCT05765201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05765201 about?
NCT05765201 is a clinical study titled "Phacoemulsification at High IOP and Physiologic IOP: Impact on Anterior and Posterior Segment Physiology". The purpose of this study is to investigate the anterior and posterior structure and functional changes and vascular alterations when performing phacoemulsification at high IOP vs low, more physiological IOP using Centurion® Vision System with Active Sentry® handpiece. These devices are approved by ...
What is the current status of trial NCT05765201?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2022-09-22. Estimated completion is 2023-05-04.
What interventions are being tested in trial NCT05765201?
The interventions under investigation include: High IOP (OTHER), Low IOP (OTHER).
Who is sponsoring clinical trial NCT05765201?
This trial is sponsored by Matthew Rauen, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.